Definium Therapeutics, Inc. SEC filings DFTX
Definium Therapeutics, Inc. has 504 filings in SEC EDGAR's recent list, going back to Jun 8, 2020. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 24, 2026 | Jun 22, 2026 |
| 424B5 | Prospectus supplement | Jun 24, 2026 | — |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 22, 2026 | Jun 22, 2026 |
| S-8 | Employee stock plan registration | Jun 16, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Other events
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Apr 22, 2026 | Apr 22, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Other events
|
Jan 12, 2026 | Jan 9, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 31, 2025 | Oct 29, 2025 |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 4, 2025 | Sep 4, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| S-8 | Employee stock plan registration | Jun 20, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| D | Filing | May 5, 2025 | — |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 21, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Other events
|
Apr 15, 2025 | Apr 15, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Other events
|
Jan 30, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 13, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 424B3 | Prospectus | Oct 22, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 17, 2024 | Oct 17, 2024 |
| 424B7 | Filing | Oct 17, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Aug 12, 2024 | Aug 9, 2024 |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| 424B5 | Prospectus supplement | Aug 9, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 28, 2024 | May 28, 2024 |
| S-3ASR | Automatic shelf registration | Jun 28, 2024 | — |
| S-8 | Employee stock plan registration | Jun 28, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2024 | Jun 10, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 10, 2024 |
| UPLOAD | Letter from the SEC | Apr 9, 2024 | — |
| S-3 | Shelf registration | Apr 2, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 1, 2024 | Apr 1, 2024 |
| D | Filing | Mar 18, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 11, 2024 | Mar 7, 2024 |
| 424B5 | Prospectus supplement | Mar 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2024 | Mar 7, 2024 |
| S-3MEF | Filing | Mar 7, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 7, 2024 | Mar 7, 2024 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K/A |
Amended current report
Other events
|
Sep 15, 2023 | Aug 14, 2023 |
| 8-K/A |
Amended current report
Other events
|
Sep 15, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 14, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jul 25, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2023 | Jun 20, 2023 |
| DEFA14A | Additional proxy material | Jun 16, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 16, 2023 | Jun 16, 2023 |
| DFAN14A | Filing | Jun 16, 2023 | — |
| DFAN14A | Filing | Jun 15, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 15, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | Jun 15, 2023 | — |
| DFAN14A | Filing | Jun 12, 2023 | — |
| DEFA14A | Additional proxy material | Jun 12, 2023 | — |
| DFAN14A | Filing | Jun 9, 2023 | — |
| DEFA14A | Additional proxy material | Jun 9, 2023 | — |
| DFAN14A | Filing | Jun 8, 2023 | — |
| DEFA14A | Additional proxy material | Jun 8, 2023 | — |
| DEFA14A | Additional proxy material | Jun 8, 2023 | — |
| DFAN14A | Filing | Jun 7, 2023 | — |
| DFAN14A | Filing | Jun 6, 2023 | — |
| DFAN14A | Filing | Jun 5, 2023 | — |
| DEFA14A | Additional proxy material | Jun 5, 2023 | — |
| DEFA14A | Additional proxy material | Jun 5, 2023 | — |
| DFAN14A | Filing | Jun 2, 2023 | — |
| DFAN14A | Filing | Jun 1, 2023 | — |
| DEFA14A | Additional proxy material | May 31, 2023 | — |
| DFAN14A | Filing | May 31, 2023 | — |
| DEFA14A | Additional proxy material | May 31, 2023 | — |
| DFAN14A | Filing | May 30, 2023 | — |
| DFAN14A | Filing | May 25, 2023 | — |
| DEFA14A | Additional proxy material | May 25, 2023 | — |
| DEFA14A | Additional proxy material | May 25, 2023 | — |
| DEFA14A | Additional proxy material | May 25, 2023 | — |
| DFAN14A | Filing | May 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 24, 2023 | May 24, 2023 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| DEFA14A | Additional proxy material | May 22, 2023 | — |
| DEFA14A | Additional proxy material | May 18, 2023 | — |
| 8-K |
Current report
Results of operations, Other events
|
May 17, 2023 | May 17, 2023 |
| DFAN14A | Filing | May 15, 2023 | — |
| DEFA14A | Additional proxy material | May 12, 2023 | — |
| DEFA14A | Additional proxy material | May 12, 2023 | — |
| DEFA14A | Additional proxy material | May 12, 2023 | — |
| DEFA14A | Additional proxy material | May 9, 2023 | — |
| DFAN14A | Filing | May 5, 2023 | — |
| DEFA14A | Additional proxy material | May 4, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| DEFC14A | Filing | May 3, 2023 | — |
| DEFA14A | Additional proxy material | May 2, 2023 | — |
| DEFA14A | Additional proxy material | May 2, 2023 | — |
| DEFA14A | Additional proxy material | May 2, 2023 | — |
| PRRN14A | Filing | May 2, 2023 | — |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFC14A | Filing | May 1, 2023 | — |
| PRER14A | Filing | May 1, 2023 | — |
| CORRESP | Letter to the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| DFAN14A | Filing | Apr 21, 2023 | — |
| PREC14A | Filing | Apr 20, 2023 | — |
| DEFA14A | Additional proxy material | Apr 18, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 18, 2023 | Apr 18, 2023 |
| PREC14A | Filing | Apr 18, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 18, 2023 | Apr 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 14, 2023 | Apr 14, 2023 |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 29, 2022 | Sep 27, 2022 |
| 424B5 | Prospectus supplement | Sep 29, 2022 | — |
| 424B5 | Prospectus supplement | Sep 27, 2022 | — |
| 8-K |
Current report
Other events
|
Sep 14, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 26, 2022 | Aug 26, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 21, 2022 | Jul 21, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Jun 2, 2022 | May 27, 2022 |
| 8-K |
Current report
Officer or director change
|
May 23, 2022 | May 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2022 | May 19, 2022 |
| EFFECT | Filing | May 16, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| DEFA14A | Additional proxy material | May 13, 2022 | — |
| CORRESP | Letter to the SEC | May 12, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2022 | May 11, 2022 |
| UPLOAD | Letter from the SEC | May 10, 2022 | — |
| S-3 | Shelf registration | May 4, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 26, 2022 | Apr 26, 2022 |
| DEFA14A | Additional proxy material | Apr 18, 2022 | — |
| DEF 14A | Proxy statement | Apr 18, 2022 | Jun 1, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 8, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations, Auditor change
|
Mar 28, 2022 | Mar 28, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2022 | Mar 24, 2022 |
| 8-K |
Current report
Change to shareholder rights
|
Feb 23, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Other events
|
Jan 25, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2022 | Jan 5, 2022 |
| 6-K | Current report (foreign issuer) | Dec 29, 2021 | Dec 29, 2021 |
| 6-K | Current report (foreign issuer) | Dec 21, 2021 | Dec 21, 2021 |
| 6-K | Current report (foreign issuer) | Dec 17, 2021 | Dec 14, 2021 |
| 6-K | Current report (foreign issuer) | Dec 17, 2021 | Dec 17, 2021 |
| 6-K | Current report (foreign issuer) | Dec 17, 2021 | Dec 17, 2021 |
| 6-K | Current report (foreign issuer) | Dec 16, 2021 | Dec 16, 2021 |
| 6-K | Current report (foreign issuer) | Dec 9, 2021 | Dec 9, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- DFTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1813814
- Former names
- Mind Medicine (MindMed) Inc. (until Jan 12, 2026)
Other Medicinal Chemicals & Botanical Products companies
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.